Announcement
Porton Pharma Solutions and Aojin Life Sciences Strategically Collaborate to Advance XDC Conjugate Drugs for Dual IND Filings
Porton Pharma Solutions
PR-12-24-NI-136Dec 12, 2024
Global Partner
A World-Class Partner for Today’s Market
Oliver Ju
Porton Pharma Solutions
PAP-Q1-2019-CL-039Mar 12, 2019
Agreement
BioDuro Announces Cooperation Agreement with Porton Pharma Solutions
Sundia
PR-M02-18-NI-006Feb 02, 2018